Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

Speculation surrounds the reversal, with Jeff Smith, CEO of Starboard, claiming Pfizer pressured the ex-executives with ...

Greek dry bulk operator Starboard has contracted a panamax for a year as Clarksons data showed period rates in the sector are ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Will this clash between a major shareholder and management, current and former, harm the stock? Or is the situation merely an ...

Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.

Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...

On Wednesday, Bourla is expected to sit down with Starboard after reports early last week that the investment firm had ...